Literature DB >> 11851650

Recreational bupropion abuse in a teenager.

Jonathan McCormick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11851650      PMCID： PMC1874291          DOI： 10.1046/j.0306-5251.2001.01538.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Cardiotoxicity associated with bupropion overdose.

Authors:  M Shrier; J E Díaz; N Tsarouhas
Journal:  Ann Emerg Med       Date:  2000-01       Impact factor: 5.721

2.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Authors:  D E Jorenby; S J Leischow; M A Nides; S I Rennard; J A Johnston; A R Hughes; S S Smith; M L Muramoto; D M Daughton; K Doan; M C Fiore; T B Baker
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

3.  Fatal bupropion overdose.

Authors:  C R Harris; J Gualtieri; G Stark
Journal:  J Toxicol Clin Toxicol       Date:  1997

Review 4.  Bupropion overdose in an adolescent.

Authors:  S Ayers; J D Tobias
Journal:  Pediatr Emerg Care       Date:  2001-04       Impact factor: 1.454

5.  A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers.

Authors:  L Miller; J Griffith
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Bupropion overdose: a 3-year multi-center retrospective analysis.

Authors:  H A Spiller; E A Ramoska; E P Krenzelok; S R Sheen; D J Borys; D Villalobos; S Muir; L Jones-Easom
Journal:  Am J Emerg Med       Date:  1994-01       Impact factor: 2.469
  6 in total
  7 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Rates of Anomalous Bupropion Prescriptions in Ontario, Canada.

Authors:  Leah S Steele; Erin M Macdonald; Tara Gomes; Simon Hollands; J Michael Paterson; Muhammad M Mamdani; David N Juurlink
Journal:  Ann Fam Med       Date:  2015 Jul-Aug       Impact factor: 5.166

3.  Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.

Authors:  Joseph J Palamar; Alberto Salomone; Marco Vincenti; Charles M Cleland
Journal:  Drug Alcohol Depend       Date:  2016-02-04       Impact factor: 4.492

Review 4.  Abuse and misuse of antidepressants.

Authors:  Elizabeth A Evans; Maria A Sullivan
Journal:  Subst Abuse Rehabil       Date:  2014-08-14

5.  Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Authors:  Laurie S Anderson; Heidi G Bell; Michael Gilbert; Julie E Davidson; Christina Winter; Monica J Barratt; Beta Win; Jeffery L Painter; Christopher Menone; Jonathan Sayegh; Nabarun Dasgupta
Journal:  JMIR Public Health Surveill       Date:  2017-02-01

6.  Is There a Potential of Misuse for Venlafaxine and Bupropion?

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

Review 7.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.